AU2001287560A1 - Agent for inhibiting adhesion of the pathogenic flora of the skin - Google Patents

Agent for inhibiting adhesion of the pathogenic flora of the skin

Info

Publication number
AU2001287560A1
AU2001287560A1 AU2001287560A AU8756001A AU2001287560A1 AU 2001287560 A1 AU2001287560 A1 AU 2001287560A1 AU 2001287560 A AU2001287560 A AU 2001287560A AU 8756001 A AU8756001 A AU 8756001A AU 2001287560 A1 AU2001287560 A1 AU 2001287560A1
Authority
AU
Australia
Prior art keywords
skin
agent
inhibiting adhesion
pathogenic flora
flora
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001287560A
Inventor
Isabelle Auzanneau
Jean-Richard Neeser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8169257&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001287560(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of AU2001287560A1 publication Critical patent/AU2001287560A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018Hydrolysed proteins; Derivatives thereof from animals from milk
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986Milk; Derivatives thereof, e.g. butter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
AU2001287560A 2000-07-14 2001-06-28 Agent for inhibiting adhesion of the pathogenic flora of the skin Abandoned AU2001287560A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00115274 2000-07-14
EP00115274 2000-07-14
PCT/EP2001/007293 WO2002005839A1 (en) 2000-07-14 2001-06-28 Agent for inhibiting adhesion of the pathogenic flora of the skin

Publications (1)

Publication Number Publication Date
AU2001287560A1 true AU2001287560A1 (en) 2002-01-30

Family

ID=8169257

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001287560A Abandoned AU2001287560A1 (en) 2000-07-14 2001-06-28 Agent for inhibiting adhesion of the pathogenic flora of the skin

Country Status (14)

Country Link
US (1) US20030161850A1 (en)
EP (1) EP1303295B1 (en)
JP (1) JP2004503597A (en)
AR (1) AR029829A1 (en)
AT (1) ATE339217T1 (en)
AU (1) AU2001287560A1 (en)
CA (1) CA2415918C (en)
DE (1) DE60123067T2 (en)
DK (1) DK1303295T3 (en)
ES (1) ES2272535T3 (en)
PE (1) PE20020147A1 (en)
PT (1) PT1303295E (en)
UY (1) UY26835A1 (en)
WO (1) WO2002005839A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
US7332179B2 (en) 2003-12-12 2008-02-19 Kimberly-Clark Worldwide, Inc. Tissue products comprising a cleansing composition
AU2008303849A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Therapeutic use of peptide YGLF and combination with KVLPVPQ
CA2797658C (en) 2010-04-21 2021-06-08 Mileutis Ltd. Casein peptide for use in the treatment of uterine infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7786M (en) * 1968-10-07 1970-03-23
FR8087M (en) * 1968-10-08 1970-07-20
US3764670A (en) * 1970-10-28 1973-10-09 Ministry Of Agriculture Polypeptidic anti-biotic substances derived from casein
DE3049038A1 (en) * 1980-12-24 1982-07-15 Marie 8000 München Hauck AGENTS FOR CONTROLLING SKIN DISEASES
US4525351A (en) * 1983-01-11 1985-06-25 Chr. Hansen's Laboratory, Inc. Liquid adherent disinfectant compositions for topical application and method of preparation
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
CH671879A5 (en) * 1987-02-26 1989-10-13 Nestle Sa
JP2631470B2 (en) * 1987-05-15 1997-07-16 雪印乳業株式会社 Infection protective agent
US5166132A (en) * 1989-03-23 1992-11-24 Gordon Arthur L Healing composition employing an enzyme-modified casein
US5681586A (en) * 1989-03-23 1997-10-28 Gordon; Arthur L. Enzyme-modified soy and soy/casein combination healing compositions
JP2673320B2 (en) * 1990-01-25 1997-11-05 雪印乳業株式会社 Anti-cariogenic agent attachment inhibitor
FR2657525B1 (en) * 1990-01-26 1994-07-29 Dubois Jacques NEW DERMO-COSMETIC PRODUCTS FOR THE CLEANING AND CARE OF THE SKIN AND / OR HAIR.
JPH10500101A (en) * 1994-05-26 1998-01-06 アボツト・ラボラトリーズ Inhibition of Haemophilus influenzae on human cells
WO1998046240A1 (en) * 1997-04-15 1998-10-22 Advanced Viral Research Corp. Topical treatment of skin diseases and eye afflictions

Also Published As

Publication number Publication date
CA2415918A1 (en) 2002-01-24
DE60123067D1 (en) 2006-10-26
JP2004503597A (en) 2004-02-05
PE20020147A1 (en) 2002-02-26
ATE339217T1 (en) 2006-10-15
ES2272535T3 (en) 2007-05-01
PT1303295E (en) 2007-01-31
EP1303295B1 (en) 2006-09-13
DE60123067T2 (en) 2007-04-12
DK1303295T3 (en) 2007-01-02
WO2002005839A1 (en) 2002-01-24
AR029829A1 (en) 2003-07-16
EP1303295A1 (en) 2003-04-23
CA2415918C (en) 2010-06-01
UY26835A1 (en) 2002-01-31
US20030161850A1 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
AU3951699A (en) The use of an anti-microbial compound for disinfection
AU2001272852A1 (en) Composition for the treatment of migraine
AU2002232385A1 (en) Elastomeric composition
EP1151667A3 (en) Plant-activating agent
AU2460100A (en) Masking agent
AU1529899A (en) Suspenders
AU2001244221A1 (en) Shower partition and shaped section for the same
HK1052465A1 (en) Use of lactic acid bacterium for the prevention ofperitonitis
AU1554301A (en) Radioprotecting agent
AU2021601A (en) Composition for the treatment of dandruff
AU2001287560A1 (en) Agent for inhibiting adhesion of the pathogenic flora of the skin
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU2001255580A1 (en) Methods and compositions for the diagnosis of schizophrenia
AU5622599A (en) Use of 5-amino-pyrazol-derivatives for combating micro-organisms
AU2001267904A1 (en) Novel antiandrogenic agent
AU5006700A (en) Polyurea composition
AU5377399A (en) Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents
AU2685700A (en) Misfet
AU4144900A (en) Method of the utilization of bactericidal composition
AU2001273847A1 (en) Polydesoxyribonucleotides for inhibiting the expression of the icam-1-gene
AU2002223611A1 (en) Use of 2-hydrazino-1,3-thiazoles as antioxidants
AU1057401A (en) Pancreatitis remedies
AU4144099A (en) Use of an agent for the prevention of gum disease
AU1345500A (en) Disinfecting agent
AU1548801A (en) Melanogenesis inhibitor